Chang-yun Xiong

Title: Chang-yun Xiong: Innovator in Anti-Viral Research

Introduction

Chang-yun Xiong is a notable inventor based in Bloomingdale, NJ (US). He has made significant contributions to the field of anti-viral research, holding a total of 3 patents. His work focuses on developing innovative solutions to combat viral infections.

Latest Patents

Among his latest patents is the invention of anti-viral cnidarins. This patent describes an isolated and purified nucleic acid molecule that encodes a polypeptide comprising at least eight contiguous amino acids with anti-viral activity. Additionally, it includes a vector comprising such a nucleic acid molecule, a host cell containing the nucleic acid, and methods for producing an antiviral polypeptide. Another significant patent involves scytovirin domain 1 related polypeptides, which includes a scytovirin domain 1 polypeptide, nucleic acids encoding the polypeptide, and methods for inhibiting viral infections.

Career Highlights

Chang-yun Xiong is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution allows him to contribute to vital research in public health and viral diseases.

Collaborations

He has collaborated with esteemed colleagues such as Barry R O'Keefe and James Brislin McMahon, further enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Chang-yun Xiong's innovative work in anti-viral research exemplifies the importance of scientific advancements in combating viral infections. His contributions through patents and collaborations continue to pave the way for future developments in this critical field.